ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 1,819.00
-3.00 (-0.16%)
At close: Jul 21, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 49.02 billion as of July 21, 2026. Its market cap has increased by 65.94% in one year.
Market Cap
49.02B
Enterprise Value
55.79B
Revenue
12.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,819.00
ChartMarket Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 49.02B, an increase of 93.42%. That is a compound annual growth rate of 10.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 49.02B | 47.61% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 63.40B |
| PanGen Biotech | 61.69B |
| ABION | 60.82B |
| Naturalendo Tech | 56.64B |
| IMGT Co.,Ltd. | 55.14B |
| Aptamer Sciences | 52.01B |
| TegoScience | 51.64B |
| Psomagen | 50.40B |